Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 19Terminated 7Unknown 3Active not recruiting 3Withdrawn 2Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Fatty Acids, Omega-3 × Clear all
NCT03936621 2019-05-07

Omega

British Columbia Cancer Agency

Phase 2 Unknown
42 enrolled
Thoracic

Lung Neoplasms

NCT00114296 2013-09-17

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
80 enrolled
Breast

Breast Neoplasms

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown
45 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡